(HBI) Hanesbrands - Ratings and Ratios
Underwear, Socks, T-Shirts, Bras, Leggings
HBI EPS (Earnings per Share)
HBI Revenue
Description: HBI Hanesbrands
Hanesbrands Inc (NYSE:HBI) is a US-based company operating in the Apparel, Accessories & Luxury Goods sub-industry. The companys quarterly tax provision is a critical aspect of its financial performance, influencing its overall profitability and cash flow.
To understand the implications of the quarterly tax provision, its essential to examine Hanesbrands financial health and operational efficiency. Key performance indicators (KPIs) such as revenue growth, gross margin, and operating margin are crucial in this analysis. The companys ability to manage its tax provision effectively can significantly impact its bottom line, as a lower tax rate can lead to increased net income.
From a macroeconomic perspective, Hanesbrands is exposed to various economic drivers, including consumer spending, raw material prices, and global trade policies. The companys performance is closely tied to the overall health of the apparel industry, which is influenced by factors such as fashion trends, seasonality, and competition. As a major player in the industry, Hanesbrands financial performance can be affected by its ability to adapt to changing consumer preferences and navigate the competitive landscape.
With a market capitalization of $1.71 billion, Hanesbrands has a relatively modest market presence. The companys price-to-earnings (P/E) ratio of 10.08 and forward P/E of 8.42 suggest that it is undervalued relative to its earnings potential. Additionally, the return on equity (RoE) of 90.78 indicates that Hanesbrands is generating significant returns for its shareholders, likely driven by efficient operations and effective capital allocation.
HBI Stock Overview
Market Cap in USD | 2,289m |
Sub-Industry | Apparel, Accessories & Luxury Goods |
IPO / Inception | 2006-09-06 |
HBI Stock Ratings
Growth Rating | -56.1% |
Fundamental | 48.9% |
Dividend Rating | 4.33% |
Return 12m vs S&P 500 | -15.5% |
Analyst Rating | 3.13 of 5 |
HBI Dividends
Currently no dividends paidHBI Growth Ratios
Growth Correlation 3m | 26.5% |
Growth Correlation 12m | -70.1% |
Growth Correlation 5y | -74.9% |
CAGR 5y | -14.52% |
CAGR/Max DD 5y | -0.18 |
Sharpe Ratio 12m | -0.34 |
Alpha | -16.11 |
Beta | 0.957 |
Volatility | 51.16% |
Current Volume | 4226.6k |
Average Volume 20d | 8261.3k |
Stop Loss | 6.1 (-3.3%) |
Signal | 0.10 |
Piotroski VR‑10 (Strict, 0-10) 2.0
Net Income (89.2m TTM) > 0 and > 6% of Revenue (6% = 209.1m TTM) |
FCFTA 0.01 (>2.0%) and ΔFCFTA -7.78pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue 18.20% (prev 17.99%; Δ 0.20pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.02 (>3.0%) and CFO 87.8m <= Net Income 89.2m (YES >=105%, WARN >=100%) |
Net Debt (2.44b) to EBITDA (449.6m) ratio: 5.43 <= 3.0 (WARN <= 3.5) |
Current Ratio 1.52 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (356.2m) change vs 12m ago 1.19% (target <= -2.0% for YES) |
Gross Margin 42.23% (prev 36.22%; Δ 6.01pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 74.16% (prev 74.32%; Δ -0.16pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 2.10 (EBITDA TTM 449.6m / Interest Expense TTM 185.9m) >= 6 (WARN >= 3) |
Altman Z'' 1.78
(A) 0.16 = (Total Current Assets 1.86b - Total Current Liabilities 1.23b) / Total Assets 4.02b |
(B) 0.08 = Retained Earnings (Balance) 306.8m / Total Assets 4.02b |
(C) 0.08 = EBIT TTM 390.8m / Avg Total Assets 4.70b |
(D) -0.06 = Book Value of Equity -214.3m / Total Liabilities 3.85b |
Total Rating: 1.78 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 48.89
1. Piotroski 2.0pt = -3.0 |
2. FCF Yield 1.28% = 0.64 |
3. FCF Margin 1.65% = 0.41 |
4. Debt/Equity 14.66 = -2.50 |
5. Debt/Ebitda 5.42 = -2.50 |
6. ROIC - WACC 7.29% = 9.11 |
7. RoE 90.78% = 2.50 |
8. Rev. Trend -78.34% = -3.92 |
9. Rev. CAGR -17.29% = -2.50 |
10. EPS Trend 25.32% = 0.63 |
11. EPS CAGR 0.08% = 0.01 |
What is the price of HBI shares?
Over the past week, the price has changed by -0.79%, over one month by +45.73%, over three months by +26.45% and over the past year by -1.10%.
Is Hanesbrands a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HBI is around 5.30 USD . This means that HBI is currently overvalued and has a potential downside of -16.01%.
Is HBI a buy, sell or hold?
- Strong Buy: 2
- Buy: 0
- Hold: 4
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the HBI price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 6.3 | -0.8% |
Analysts Target Price | 6.8 | 7.1% |
ValueRay Target Price | 5.8 | -8.9% |
Last update: 2025-08-21 02:49
HBI Fundamental Data Overview
CCE Cash And Equivalents = 220.3m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 13.4792
P/E Forward = 10.7181
P/S = 0.6465
P/B = 13.7162
P/EG = 0.1924
Beta = 1.397
Revenue TTM = 3.49b USD
EBIT TTM = 390.8m USD
EBITDA TTM = 449.6m USD
Long Term Debt = 2.27b USD (from longTermDebt, last quarter)
Short Term Debt = 173.8m USD (from shortTermDebt, last quarter)
Debt = 2.44b USD (Calculated: Short Term 173.8m + Long Term 2.27b)
Net Debt = 2.44b USD (from netDebt column, last quarter)
Enterprise Value = 4.51b USD (2.29b + Debt 2.44b - CCE 220.3m)
Interest Coverage Ratio = 2.10 (Ebit TTM 390.8m / Interest Expense TTM 185.9m)
FCF Yield = 1.28% (FCF TTM 57.7m / Enterprise Value 4.51b)
FCF Margin = 1.65% (FCF TTM 57.7m / Revenue TTM 3.49b)
Net Margin = 2.56% (Net Income TTM 89.2m / Revenue TTM 3.49b)
Gross Margin = 42.23% ((Revenue TTM 3.49b - Cost of Revenue TTM 2.01b) / Revenue TTM)
Tobins Q-Ratio = -21.03 (set to none) (Enterprise Value 4.51b / Book Value Of Equity -214.3m)
Interest Expense / Debt = 1.95% (Interest Expense 47.5m / Debt 2.44b)
Taxrate = 12.85% (from quarterly Income Tax Expense: 12.6m / 98.1m)
NOPAT = 340.6m (EBIT 390.8m * (1 - 12.85%))
Current Ratio = 1.52 (Total Current Assets 1.86b / Total Current Liabilities 1.23b)
Debt / Equity = 14.66 (Debt 2.44b / last Quarter total Stockholder Equity 166.4m)
Debt / EBITDA = 5.42 (Net Debt 2.44b / EBITDA 449.6m)
Debt / FCF = 42.30 (Debt 2.44b / FCF TTM 57.7m)
Total Stockholder Equity = 98.3m (last 4 quarters mean)
RoA = 2.22% (Net Income 89.2m, Total Assets 4.02b )
RoE = 90.78% (Net Income TTM 89.2m / Total Stockholder Equity 98.3m)
RoCE = 16.53% (Ebit 390.8m / (Equity 98.3m + L.T.Debt 2.27b))
RoIC = 12.78% (NOPAT 340.6m / Invested Capital 2.66b)
WACC = 5.49% (E(2.29b)/V(4.73b) * Re(9.54%)) + (D(2.44b)/V(4.73b) * Rd(1.95%) * (1-Tc(0.13)))
Shares Correlation 5-Years: 60.0 | Cagr: 0.27%
Discount Rate = 9.54% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 64.00% ; FCFE base≈232.8m ; Y1≈152.9m ; Y5≈69.9m
Fair Price DCF = 3.08 (DCF Value 1.09b / Shares Outstanding 353.8m; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: -78.34 | Revenue CAGR: -17.29%
Rev Growth-of-Growth: 23.23
EPS Correlation: 25.32 | EPS CAGR: 0.08%
EPS Growth-of-Growth: 105.9
Additional Sources for HBI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle